We are live on ! Find out more
CP

Catalys Pacific Portfolio holdings

AUM $231M
1-Year Est. Return 83.19%
This Fund
S&P 500
This Quarter Est. Return
+174.11%
1 Year Est. Return
+83.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$351M
AUM Growth
+$220M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLYS icon
1
Mineralys Therapeutics
MLYS
$2.25B
$338M 96.09%
8,903,838
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$708M
$13.7M 3.91%
1,167,114

Similar funds

Catalys Pacific's Q3 2025 Portfolio in Review

As of Q3 2025, Catalys Pacific held 2 positions worth $351M, up 167% from $132M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Catalys Pacific's ten largest holdings make up 100% of its $351M portfolio in Q3 2025.
  • Catalys Pacific opened 0 new positions and closed 0 in Q3 2025.
  • Catalys Pacific's portfolio value rose 167% quarter-over-quarter to $351M.

Based on Catalys Pacific's 13F filing for Q3 2025, filed 14 Nov 2025.